Gilead Sciences, Inc. (GILD)
NASDAQ·Healthcare·Drug Manufacturers - General
$124.82
-1.89%
Mkt Cap $155.93B
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (90 analysts)
$158.71
Range $105.00 – $180.00
Implied Upside
+27.2%
Consensus $158.71 vs current $124.82